Danh mục: PRNews

SINGAPORE, Aug. 6, 2018 /PRNewswire/ — A Memorandum of Understanding was signed on Friday 3 August by Tan Tock Seng Hospital (TTSH)’s Centre for Asian Nursing Studies (CANS), the Wound…

Advances in research and development Half-year net sales of 8.6 billion euros Satisfactory currency-adjusted growth in all businesses Major investments in sites in Germany and France INGELHEIM, Germany, Aug. 1,…

BANGKOK, Aug. 1, 2018 /PRNewswire/ — The Thailand Board of Investment (BOI) has agreed to expand seven additional sites as “Food Innopolis”, aiming to create value-added agricultural products nationwide through…

NANJING, China, Aug. 3, 2018 /PRNewswire/ — IMPACT Therapeutics, Inc. (IMPACT), a China-based clinical-stage biopharmaceutical company dedicated to the discovery and development of “best-in-class” medicine for the treatment of cancer…

— 2Q18 Total Sales Up 25.5% YoY and Non-GAAP Adjusted Net Income Down 2.8% YoY in RMB terms, or Total Sales Up 34.8% YoY to $120.4 Million and Net Income…

HANGZHOU, China and SHAOXING, China, Aug. 1, 2018 /PRNewswire/ — Ascletis announced today it has received the acceptance letter from the China Food and Drug Administration (CFDA) for Ravidasvir (RDV,…

– Detection of cancer biomarkers within 10 minutes with a single drop of blood – markB is a point-of-care testing device, that can be used by anyone – After beginning…

ISNES, Belgium, Aug. 1, 2018 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced that its first product the “Total Nu.Q™ Assay” research use only (RUO) kit, is ready…

– Direct sharing of symptoms and treatment processes and provision of compensation for the sharing of information. – Expected to release blockchain-based “Humanscape” later this year. SEOUL, South Korea, Aug.…

-Q2 Performance was In-line with Expectations YONGIN, South Korea, July 31, 2018 /PRNewswire/ — GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today…